Afghanistan vs Mauritania: Previously treated cases tested for RR-/MDR-TB
Afghanistan
100.0%
in 2024
Mauritania
100.0%
in 2023
Afghanistan rank
1st
Mauritania rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Afghanistan
- Mauritania
How they compare
Afghanistan currently reports 100.0% against 100.0% in Mauritania, a difference of 0.0%.
The two have swapped places 2 times across 8 shared years of data; in 2015 it was Mauritania ahead.
Afghanistan ranks 1st and Mauritania ranks 1st of 180 countries.
Across the 2 decades both report, Afghanistan averaged higher in 1 and Mauritania in 1.
Head to head by decade
| Decade | Afghanistan | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 70.3% | 52.9% | 17.4% | Afghanistan |
| 2020s | 85.3% | 100.0% | 14.7% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Afghanistan or Mauritania?
- Afghanistan, at 100.0% against 100.0% in Mauritania as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Afghanistan and Mauritania?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Mauritania?
- 8 years are reported by both, from 2015 to 2023.
- How do Afghanistan and Mauritania rank globally for previously treated cases tested for rr-/mdr-tb?
- Afghanistan ranks 1st and Mauritania ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.